Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Biochemistry|January 14, 1986
Distances between active site probes in glutamine synthetase from Escherichia coli: fluorescence energy transfer in free and in stacked dodecamersM R Maurizi, P G Kasprzyk, A GinsburgBiochemistry|April 12, 1983
Fluorescence energy transfer experiments with Escherichia coli carbamoyl-phosphate synthetaseP G Kasprzyk, P M Anderson, J J VillafrancaAnnals of the New York Academy of Sciences|February 24, 2001
Homocamptothecins: E-ring modified CPT analoguesO Lavergne, D Demarquay, P G Kasprzyk, et al.Cancer Research|May 15, 1992
Therapy of an animal model of human gastric cancer using a combination of anti-erbB-2 monoclonal antibodiesP G Kasprzyk, S U Song, P P Di Fiore, et al.Seminars in Cancer Biology|October 1, 1990
Implications of erbB-2 overexpression for basic science and clinical medicineC R King, M H Kraus, P P DiFiore, et al.Anti-Cancer Agents in Medicinal Chemistry|December 17, 2008
CDC25 inhibitors as anticancer agents are moving forwardM-C Brezak, P G Kasprzyk, M-O Galcera, et al.Proceedings of the National Academy of Sciences of the United States of America|July 1, 1992
Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxinJ K Batra, P G Kasprzyk, R E Bird, et al.Breast Cancer Research and Treatment|January 1, 1996
Preclinical testing of an anti-erbB-2 recombinant toxinC R King, P G Kasprzyk, P H Fischer, et al.The Journal of Biological Chemistry|July 15, 1994
Improved binding and antitumor activity of a recombinant anti-erbB2 immunotoxin by disulfide stabilization of the Fv fragmentY Reiter, U Brinkmann, S H Jung, et al.Molecular Carcinogenesis|January 1, 1993
Effect of gastrin-releasing peptide on the pancreatic tumor cell line (Capan)I Avis, M Jett, P G Kasprzyk, et al.Pageof 3